MIT Tech Review 'Job Titles of the Future': Nature's Drug Designer

MIT Technology Review·low signal

MIT Technology Review profiled chemist Tim Cernak, who after nearly two decades in Big Pharma (including precision therapies for cancer, HIV, and diabetes at Merck) now works at the intersection of nature-derived chemistry and computational drug design. The piece frames an emerging role blending domain chemistry with AI-assisted molecular design. A glimpse at how AI is reshaping specialized scientific careers.